Anúncio
Anúncio
BIOA
BioAge Labs, Inc. Common Stock
14.02
USDPatrocinado
+0.10
+0.72%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
14.23
+0.21
+1.53%
Relatórios de Lucros BIOA
Rácio de surpresa positiva
BIOA separação 3 de 5 últimas estimativas.
60%
Próximo Relatório
Data do Próximo Relatório
18 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.45M
/-$0.78
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-29.24%
/+39.29%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/-60.41%
BioAge Labs, Inc. Common Stock earnings per share and revenue
On 06 de nov. de 2025, BIOA reported earnings of -0.56 USD per share (EPS) for Q3 25, beating the estimate of -0.59 USD, resulting in a 6.02% surprise. Revenue reached 2.05 milhão, compared to an expected 1.06 milhão, with a 94.25% difference. The market reacted with a -2.81% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 analistas forecast an EPS of -0.78 USD, with revenue projected to reach 1.45 milhão USD, implying an aumentar of 39.29% EPS, and diminuir of -29.24% in Revenue from the last quarter.
FAQ
What were BioAge Labs, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, BioAge Labs, Inc. Common Stock reported EPS of -$0.56, beating estimates by 6.02%, and revenue of $2.05M, 94.25% above expectations.
How did the market react to BioAge Labs, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -2.81%, changed from $7.47 before the earnings release to $7.26 the day after.
When is BioAge Labs, Inc. Common Stock expected to report next?
The next earning report is scheduled for 18 de mar. de 2026.
What are the forecasts for BioAge Labs, Inc. Common Stock's next earnings report?
Based on 7
analistas, BioAge Labs, Inc. Common Stock is expected to report EPS of -$0.78 and revenue of $1.45M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio